Suppr超能文献

眼附属器淋巴瘤患者生存相关的临床特征。

Clinical features associated with survival of patients with lymphoma of the ocular adnexa.

作者信息

Jenkins C, Rose G E, Bunce C, Cree I, Norton A, Plowman P N, Moseley I, Wright J E

机构信息

Orbital Clinic Moorfields Eye Hospital City Road, London, UK.

出版信息

Eye (Lond). 2003 Oct;17(7):809-20. doi: 10.1038/sj.eye.6700379.

Abstract

PURPOSE

Although systemic or eyelid involvement by ocular adnexal lymphoma carries a worse prognosis, there have been few reports of the outcome in relation to clinical presentation. The outcome of malignant ocular adnexal lymphoma was, therefore, related to presenting clinical symptoms and signs.

DESIGN AND METHODS

A retrospective, noncomparative case-note review of 326 patients treated in the Orbital Clinic at Moorfields Eye Hospital. The associations between presenting symptoms or signs and three outcome measures (v.i.) were assessed by univariate and multiple variable regression together with Kaplan-Meier analysis.

MAIN OUTCOME MEASURES

(i) Presence of extra-orbital disease at the time of presentation; (ii) development of systemic lymphoma after new presentation with solely ocular adnexal disease; and (iii) death attributable to widespread lymphoma.

RESULTS

Presentation with disseminated disease was rarer with over 1 year's ophthalmic symptoms (odds ratio (OR) 0.7; 95% CI 0.5-0.9) and much more frequent with bilateral adnexal disease (OR 5.8; 95% CI 3.0-11.2). With solely adnexal disease at presentation, subsequent extra-orbital lymphoma was more frequent and earlier with lacrimal gland disease (as compared to those without; hazard ratio (HR) 1.9; 95% CI 1.2-4.5) or with eyelid disease (compared to those without; HR 2.4; 95% CI 1.2-4.5), or with bilateral disease (compared to unilateral disease; HR 2.6; 95% CI 1.4-5.2). Prior or concurrent systemic disease was the most significant predictive factor for lymphoma-related death (HR 6.8; 95% CI 4.3-10.9), but tumour-related death was also commoner and earlier with bilateral disease (HR 2.4; 95% CI 1.4-4.0) or where a relative afferent papillary defect was present (HR 2.8; 95% CI 1.6-4.9). Similarly, the rate of tumour-related death was slightly less where symptoms had been present for more than a year (HR 0.8; 95% CI 0.7-1.0) and slightly greater in the elderly (HR 1.03; 95% CI 1.01-1.05). Conjunctival lymphoma had the lowest rate of extra-orbital spread and lymphoma-related death, the rate of these two events being sequentially greater for patients with predominantly deep orbital lymphoma, lacrimal gland lymphoma, or eyelid lymphoma.

CONCLUSION

These data suggest that presenting symptoms and signs of patients with ocular adnexal lymphoma are significantly associated with the risk of systemic disease at orbital presentation, the rate of subsequent spread, and the rate of lymphoma-related death.

摘要

目的

尽管眼附属器淋巴瘤累及全身或眼睑时预后较差,但关于其临床表现与预后关系的报道较少。因此,本研究旨在探讨恶性眼附属器淋巴瘤的预后与临床表现之间的关系。

设计与方法

对在摩尔菲尔德眼科医院眼眶科接受治疗的326例患者进行回顾性、非对照性病例记录审查。通过单因素和多因素回归分析以及Kaplan-Meier分析,评估临床表现与三项预后指标(见下文)之间的关联。

主要预后指标

(i)就诊时是否存在眶外疾病;(ii)初发时仅患有眼附属器疾病,之后是否发展为全身性淋巴瘤;(iii)因广泛淋巴瘤导致的死亡。

结果

出现播散性疾病的情况在有超过1年眼科症状的患者中较少见(比值比(OR)0.7;95%可信区间0.5 - 0.9),而在双侧附属器疾病患者中更为常见(OR 5.8;95%可信区间3.0 - 11.2)。初发时仅患有附属器疾病,随后眶外淋巴瘤在泪腺疾病患者中(与无泪腺疾病者相比;风险比(HR)1.9;95%可信区间1.2 - 4.5)、眼睑疾病患者中(与无眼睑疾病者相比;HR 2.4;95%可信区间1.2 - 4.5)或双侧疾病患者中(与单侧疾病相比;HR 2.6;95%可信区间1.4 - 5.2)出现得更频繁且更早。既往或并发全身性疾病是淋巴瘤相关死亡的最显著预测因素(HR 6.8;95%可信区间4.3 - 10.9),但在双侧疾病患者中(HR 2.4;95%可信区间1.4 - 4.0)或存在相对传入性瞳孔障碍的患者中(HR 2.8;95%可信区间1.6 - 4.9),肿瘤相关死亡也更常见且更早。同样,症状出现超过1年的患者肿瘤相关死亡率略低(HR 0.8;95%可信区间0.7 - 1.0),而老年患者中略高(HR 1.03;95%可信区间1.01 - 1.05)。结膜淋巴瘤的眶外扩散率和淋巴瘤相关死亡率最低,对于主要为深部眼眶淋巴瘤、泪腺淋巴瘤或眼睑淋巴瘤的患者,这两个事件的发生率依次更高。

结论

这些数据表明,眼附属器淋巴瘤患者的临床表现与眼眶就诊时全身性疾病的风险、随后的扩散率以及淋巴瘤相关死亡率显著相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验